APA

Maira S., Stauffer F., Brueggen J., Furet P., Schnell C., Fritsch C., Brachmann S., Chène P., De Pover A., Schoemaker K., Fabbro D., Gabriel D., Simonen M., Murphy L., Finan P., Sellers W. & García-Echeverría C. (20080908). Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity. : Molecular cancer therapeutics.

Chicago

Maira Sauveur-Michel, Stauffer Frédéric, Brueggen Josef, Furet Pascal, Schnell Christian, Fritsch Christine, Brachmann Saskia, Chène Patrick, De Pover Alain, Schoemaker Kevin, Fabbro Doriano, Gabriel Daniela, Simonen Marjo, Murphy Leon, Finan Peter, Sellers William and García-Echeverría Carlos. 20080908. Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity. : Molecular cancer therapeutics.

Harvard

Maira S., Stauffer F., Brueggen J., Furet P., Schnell C., Fritsch C., Brachmann S., Chène P., De Pover A., Schoemaker K., Fabbro D., Gabriel D., Simonen M., Murphy L., Finan P., Sellers W. and García-Echeverría C. (20080908). Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity. : Molecular cancer therapeutics.

MLA

Maira Sauveur-Michel, Stauffer Frédéric, Brueggen Josef, Furet Pascal, Schnell Christian, Fritsch Christine, Brachmann Saskia, Chène Patrick, De Pover Alain, Schoemaker Kevin, Fabbro Doriano, Gabriel Daniela, Simonen Marjo, Murphy Leon, Finan Peter, Sellers William and García-Echeverría Carlos. Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity. : Molecular cancer therapeutics. 20080908.